DFDA

Sacral Neuromodulation (SNM)

Treatment for Interstitial Cystitis

Typical Dosage: Programmable stimulation settings

Effectiveness
68%
Safety Score
68%
Clinical Trials
1
Participants
3K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
68
DangerousModerateSafe
Treatment Details
Dosage Range
Programmable stimulation settings
Time to Effect
1-4 weeks (after activation)
Treatment Duration
Lifetime (device), 5-10 years (battery replacement)
Evidence Quality
HIGH
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$800
Side Effect Mgmt:$500
Total Annual:$5,400
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$70,000/QALY
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$9,000
Cost per Remission
$54,000
Sacral Neuromodulation (SNM) Outcomes

for Interstitial Cystitis

Efficacy Outcomes
Overall Effectiveness
+68%
Response Rate
+60%
Remission Rate
+10%
Common Side Effects
Pain at implant site
+15%
Lead migration
+8%
Infection
+5%
Device malfunction
+7%
Revision surgery
+15%

Sources:

nih.gov
urotoday.com
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Sacral Neuromodulation (SNM) in Interstitial Cystitis

SNM vs. HBOT for Refractory IC/BPS

NCT07091266COMPLETEDNA
View Study
88 participants
INTERVENTIONAL
Shiyan, China
Started: Feb 1, 2021